Flatiron Health, Purchased By Roche, Signs Three-Year Deal With Bristol-Myers

Flatiron Health was purchased by Roche, the Swiss drug giant, for $1.9 billion in February. At the time, the New York startup said that it would still be open for business with other drug companies. It wasn’t kidding.